Hyperthermia-mediated changes in the tumor immune microenvironment using iron oxide nanoparticles

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Immunology

Background:

• Iron oxide nanoparticles (IONPs) are explored for tumor hyperthermia.
• Hyperthermia can modulate the tumor immune microenvironment.
• Aggressive breast cancer models exhibit immunosuppressive tumors.

Purpose of the Study:

• Investigate the direct impact of IONP-induced hyperthermia on tumor-resident immune cells.
• Compare intratumoral versus systemic IONP administration.
• Evaluate the combination of IONP hyperthermia and immune checkpoint inhibitors.

Main Methods:

• Utilized the orthotopic 4T1 mouse model for aggressive breast cancer.
• Administered IONPs via intratumoral injection and systemic delivery.
• Applied alternating magnetic fields (AMF) for hyperthermia induction.
• Analyzed immune cell subpopulation changes post-treatment.

Main Results:

• Both intratumoral and systemic IONP hyperthermia reduced tumor-resident immune cells.
• Systemic IONP administration showed superior reduction of innate and adaptive immune cells.
• Depleting dysfunctional immune cells enabled repopulation with effector cells after immunotherapy.

Conclusions:

• Systemic IONP hyperthermia is a promising strategy for immune cell modulation in breast cancer.
• Combining IONP hyperthermia with immune checkpoint inhibitors can overcome tumor immunosuppression.
• This approach leads to significant tumor cell population reduction.